Hydroxychloroquine safety and potential efficacy as an antiviral prophylaxis in light of potential wide-spread use in COVID-19: a multinational, large-scale network
cohort and self-controlled case series study

03/04/2020
30/01/2025
EU PAS number:
EUPAS34497
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

Optum United States, PanTher United States, CCAE United States, MDCR, MDCD, JMDC

Data sources (types)

Administrative healthcare records (e.g., claims)
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No